Acorah Software Products - Accounts Production 16.1.300 false true false true No description of principal activity 1 December 2023 30 November 2024 30 November 2024 10459791 Dr Stylianos KAMPAKIS iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10459791 2023-11-30 10459791 2024-11-30 10459791 2023-12-01 2024-11-30 10459791 frs-core:CurrentFinancialInstruments 2024-11-30 10459791 frs-bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 10459791 frs-bus:FilletedAccounts 2023-12-01 2024-11-30 10459791 frs-bus:Micro-entities 2023-12-01 2024-11-30 10459791 frs-bus:AuditExempt-NoAccountantsReport 2023-12-01 2024-11-30 10459791 frs-bus:Director1 2023-12-01 2024-11-30
Registered number: 10459791
KAMPAKIS AND CO. LTD
Unaudited Financial Statements
For The Year Ended 30 November 2024
Statement of Financial Position
Registered number: 10459791
2024
£
Fixed assets 162,316
Current assets 36,741
Prepayments and accrued income 275
Creditors: Amounts Falling Due Within One Year (18,709 )
NET CURRENT ASSETS 18,307
TOTAL ASSETS LESS CURRENT LIABILITIES 180,623
NET ASSETS 180,623
CAPITAL AND RESERVES 180,623

Notes

1. General Information
KAMPAKIS AND CO. LTD is a private company, limited by shares, incorporated in England & Wales, registered number 10459791 . The registered office is 5 Brunswick Park Gardens, London, N11 1EJ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2
2
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Stylianos KAMPAKIS
Director
21/03/2025